Targeting Epigenetics in the Development of New Diagnostic Applications-Lessons from Autoimmune Diseases

Hui Min Chen, Frederic Chedin, Christopher Chang, Patrick S Leung

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Epigenetic mechanisms, including DNA methylation and histone modifications, account for a highly sophisticated regulatory system that is fundamental to the regulation of many cellular processes, including gene and microRNA expression, DNA-protein interactions, suppression of transposable element mobility, cellular differentiation, embryogenesis, X-chromosome inactivation, and genomic imprinting. Extensive data has shown that epigenetic changes are associated with multiple human diseases. In the context of autoimmune diseases, especially systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS), evidence suggests that epigenetic changes may in fact play a causal role in the pathophysiology of these disorders. Understanding the epigenetics of autoimmune diseases may provide insights into clinical applications implicated in diagnostic, prognostic biomarkers and the prediction of drug responses, as well as new therapeutic interventions that may modulate disease-related epigenetic alterations and thereby improve patient outcomes.

Original languageEnglish (US)
Title of host publicationEpigenetics and Dermatology
PublisherElsevier Inc.
Pages409-441
Number of pages33
ISBN (Print)9780128012727, 9780128009574
DOIs
StatePublished - Feb 17 2015

Fingerprint

Epigenomics
Autoimmune Diseases
Pharmacological Biomarkers
Histone Code
DNA Transposable Elements
Genomic Imprinting
Chromosomes
X Chromosome Inactivation
MicroRNAs
Histones
DNA Methylation
Genes
Systemic Lupus Erythematosus
Multiple Sclerosis
Embryonic Development
Rheumatoid Arthritis
DNA
Gene Expression
Proteins
Therapeutics

Keywords

  • DNA methylation
  • Epigenetic perturbations
  • Histone modifications
  • Multiple sclerosis
  • Rheumatoid arthritis
  • Systemic lupus erythematosus

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Targeting Epigenetics in the Development of New Diagnostic Applications-Lessons from Autoimmune Diseases. / Chen, Hui Min; Chedin, Frederic; Chang, Christopher; Leung, Patrick S.

Epigenetics and Dermatology. Elsevier Inc., 2015. p. 409-441.

Research output: Chapter in Book/Report/Conference proceedingChapter

Chen, Hui Min ; Chedin, Frederic ; Chang, Christopher ; Leung, Patrick S. / Targeting Epigenetics in the Development of New Diagnostic Applications-Lessons from Autoimmune Diseases. Epigenetics and Dermatology. Elsevier Inc., 2015. pp. 409-441
@inbook{64f9219e10c540fb84ba761af2664a53,
title = "Targeting Epigenetics in the Development of New Diagnostic Applications-Lessons from Autoimmune Diseases",
abstract = "Epigenetic mechanisms, including DNA methylation and histone modifications, account for a highly sophisticated regulatory system that is fundamental to the regulation of many cellular processes, including gene and microRNA expression, DNA-protein interactions, suppression of transposable element mobility, cellular differentiation, embryogenesis, X-chromosome inactivation, and genomic imprinting. Extensive data has shown that epigenetic changes are associated with multiple human diseases. In the context of autoimmune diseases, especially systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS), evidence suggests that epigenetic changes may in fact play a causal role in the pathophysiology of these disorders. Understanding the epigenetics of autoimmune diseases may provide insights into clinical applications implicated in diagnostic, prognostic biomarkers and the prediction of drug responses, as well as new therapeutic interventions that may modulate disease-related epigenetic alterations and thereby improve patient outcomes.",
keywords = "DNA methylation, Epigenetic perturbations, Histone modifications, Multiple sclerosis, Rheumatoid arthritis, Systemic lupus erythematosus",
author = "Chen, {Hui Min} and Frederic Chedin and Christopher Chang and Leung, {Patrick S}",
year = "2015",
month = "2",
day = "17",
doi = "10.1016/B978-0-12-800957-4.00019-9",
language = "English (US)",
isbn = "9780128012727",
pages = "409--441",
booktitle = "Epigenetics and Dermatology",
publisher = "Elsevier Inc.",

}

TY - CHAP

T1 - Targeting Epigenetics in the Development of New Diagnostic Applications-Lessons from Autoimmune Diseases

AU - Chen, Hui Min

AU - Chedin, Frederic

AU - Chang, Christopher

AU - Leung, Patrick S

PY - 2015/2/17

Y1 - 2015/2/17

N2 - Epigenetic mechanisms, including DNA methylation and histone modifications, account for a highly sophisticated regulatory system that is fundamental to the regulation of many cellular processes, including gene and microRNA expression, DNA-protein interactions, suppression of transposable element mobility, cellular differentiation, embryogenesis, X-chromosome inactivation, and genomic imprinting. Extensive data has shown that epigenetic changes are associated with multiple human diseases. In the context of autoimmune diseases, especially systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS), evidence suggests that epigenetic changes may in fact play a causal role in the pathophysiology of these disorders. Understanding the epigenetics of autoimmune diseases may provide insights into clinical applications implicated in diagnostic, prognostic biomarkers and the prediction of drug responses, as well as new therapeutic interventions that may modulate disease-related epigenetic alterations and thereby improve patient outcomes.

AB - Epigenetic mechanisms, including DNA methylation and histone modifications, account for a highly sophisticated regulatory system that is fundamental to the regulation of many cellular processes, including gene and microRNA expression, DNA-protein interactions, suppression of transposable element mobility, cellular differentiation, embryogenesis, X-chromosome inactivation, and genomic imprinting. Extensive data has shown that epigenetic changes are associated with multiple human diseases. In the context of autoimmune diseases, especially systemic lupus erythematosus (SLE), rheumatoid arthritis (RA), and multiple sclerosis (MS), evidence suggests that epigenetic changes may in fact play a causal role in the pathophysiology of these disorders. Understanding the epigenetics of autoimmune diseases may provide insights into clinical applications implicated in diagnostic, prognostic biomarkers and the prediction of drug responses, as well as new therapeutic interventions that may modulate disease-related epigenetic alterations and thereby improve patient outcomes.

KW - DNA methylation

KW - Epigenetic perturbations

KW - Histone modifications

KW - Multiple sclerosis

KW - Rheumatoid arthritis

KW - Systemic lupus erythematosus

UR - http://www.scopus.com/inward/record.url?scp=84940053574&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84940053574&partnerID=8YFLogxK

U2 - 10.1016/B978-0-12-800957-4.00019-9

DO - 10.1016/B978-0-12-800957-4.00019-9

M3 - Chapter

AN - SCOPUS:84940053574

SN - 9780128012727

SN - 9780128009574

SP - 409

EP - 441

BT - Epigenetics and Dermatology

PB - Elsevier Inc.

ER -